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ABSTRACT 
Leaves of Tabebuia bahamensis, collected on 
Abaco Island, Bahamas, were dried and extracted 
with dichloromethane to yield a crude extract.  
Using preparative flash column chromatography 
on silica gel, enabled the isolation of ursolic acid 
with an excellent yield of 2.06 percent based on the 
mass of dry leaves.  Both the crude leaf extract 
and ursolic acid produced selective in-vitro 
cytotoxic activity on tumor cells from human 
mammary and bladder tissue.  Ursolic acid also 
demonstrated antibacterial activity against 
Staphylococcus aureus.  
 
INTRODUCTION 
 Commonly known as “five fingers,” Tabebuia 
bahamensis (North.) Britton, is a small tree in the 
Bignoniaceae family along with 110 other genera 
consisting of 650 species of flowering plants of 
which about 100 species belong to the Tabebuia 
genus (Rahmatullah et al., 2010; Ospina et al., 2013). 
The Five Fingers tree, which is endemic to the 
Bahamas, is now commonly observed in tropical and 
subtropical habitats, has small leaves with 3-5 leaflets 
that are slender, green on the upper surface and 
strongly whitish on the lower surface.  The tree is 
slim with straight upright branches and grows well in 
properly drained, alkaline or acidic soils.  Flowers 
vary in color from white to pink and the tree blooms 
throughout the year (Popenoe, 1980).   
Several species of the genus Tabebuia hold 
ethnopharmacological and ethnobotanical impor-
tance.  In the Bahamas, the leaves of T. bahamensis 
are used as a tea for “bodily strain” and for relief of 
backache (Higgs, 1969). The leaf decoction of T. 
bahamensis has been used as a sex stimulant and 
aphrodisiac (Halberstein, 2005), and the plant has 
been an essential component of a “love potion” 
prepared on Andros Island of the Bahamas 
(Eshbaugh, 2014). 
In the current study, the biological activity of 
crude leaf extract from T. bahamensis and the 
isolation of ursolic acid in large quantities are 
detailed.  To our knowledge, this is the first 
examination of the phytochemistry of T. bahamensis. 
 
MATERIALS AND METHODS 
Plant material.  Leaves of T. bahamensis were 
collected December 16, 2000, on Abaco Island, 
Bahamas (26° 31.092′ N, 77° 4.258 W, 13 m asl).  
The plant was identified in the field by a qualified 
local ethnobotanical informant (Dolly Davis), and 
verified with a field guide (Nickrent et al., 1991).  A 
voucher specimen (TABA2000) has been deposited 
in the herbarium of the University of Alabama in 
Huntsville.  The leaves were cleaned of debris, 
chopped, air dried, and 594 g of chopped dry leaves 
were extracted by refluxing with dichloromethane for 
four hours using a Soxhlet extractor.   The solvent 
was subsequently evaporated to yield 50.1 g of crude 
leaf extract. 
Preparative flash chromatography. The 
crude, dichloromethane leaf extract (25.0 g) was 
subjected to flash chromatography (Figure 1) using 
silica gel (230-400 mesh),  in a 90 cm long × 5 cm 
diameter glass column.  A hexane/ethyl acetate step 
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gradient (hexane, 9:1 hexane/EtOAc, 4:1 hexane/EtOAc, 
1:1 hexane/EtOAc, EtOAc) in 200-mL fractions, was 
used to separate the constituents with detection of 
eluates by TLC.  Fractions F51-F90 had similar TLC 
eluates and were thus combined and recrystallized in 
EtOAc/pentane to yield 6.10 g ursolic acid as a 
colorless crystalline solid. 
NMR spectroscopic characterization.  NMR 
spectra were measured at 500 MHz on a Varian 
INOVA spectrometer in DMSO-d6.  1H NMR (500 
MHz, DMSO-d6) δ 11.93 (s, 1H), 5.13 (t, J = 3.7 Hz, 
1H), 4.29 (d, J = 5.1 Hz, 1H), 3.00 (dt, J = 10.1, 5.0 
Hz, 1H), 2.10 (dd, J = 11.4, 1.6 Hz, 1H), 1.04 (s, 3H), 
0.91 (s, 3H), 0.89 (s, 3H), 0.86 (s, 3H), 0.81 (d, J = 
6.4 Hz, 3H), 0.75 (s, 3H), 0.67 (s, 3H). 13C NMR 
(126 MHz, DMSO-d6) δ 178.24, 138.17, 124.55, 
76.81, 54.76, 52.36, 47.00, 46.81, 41.63, 39.09, 
38.49, 38.42, 38.37, 38.21, 36.52, 36.30, 32.69, 
30.17, 28.25, 27.53, 26.98, 23.79, 23.26, 22.84, 
21.07, 17.99, 17.01, 16.91, 16.07, 15.22.  The NMR 
spectra were consistent with ursolic acid 
(Moghaddam et al., 2007; Silva et al., 2008; Keat et 
al., 2010). 
Antimicrobial screening.  The crude leaf 
extract and ursolic acid were screened for anti-
microbial activity against the Gram-positive bacteria 
Bacillus cereus (ATCC No. 14579), and 
Staphylococcus aureus (ATCC No. 29213).  Anti- 
microbial activity of the crude leaf extract and ursolic 
acid against Gram-negative bacteria were tested with 
Pseudomonas aeruginosa (ATCC No. 27853) and 
Escherichia coli (ATCC No. 10798), and the fungi 
Candida albicans (ATCC No.10231) and Aspergillus 
niger (ATCC No. 16888).  Minimum inhibitory 
concentrations (MICs) were determined using the 
microbroth dilution technique as previously described 
(Setzer et al., 2003; Schmidt et al., 2006).   
Cytotoxicity screening.  In-vitro cytotoxicity 
screening was tested against human MCF-7 breast 
adenocarcinoma (ATCC No. HTB-22), human SK-
Mel-28 malignant melanoma (ATCC No. HTB-72), 
human Hep G2 hepatocellular carcinoma (ATCC No. 
HB-8065), human MDA-MB-231 breast adeno-
carcinoma (ATCC No. HTB-26), and human 5637 
bladder carcinoma (ATCC No. HTB-9) cells as 
previously described (Setzer et al., 2003; Schmidt et 
al., 2006).   
 
 
 
 
 
 
 
 
Figure 1.  Chromatographic separation scheme for Tabebuia 
bahamensis CH2Cl2 crude leaf extract. 
RESULTS  
 Crude leaf extract of Tabebuia bahamensis 
demonstrated selective cytotoxic activity against 
several human tumor cell lines.  The extract was non-
toxic to SK-Mel-38 and Hep-G2 cells, marginally 
toxic to MDA-MB-231 cells (58.8 ± 7.3 % kill at 100 
μg/mL), and notably toxic to 5637 bladder tumor 
cells (93.0 ± 6.9 % kill at 100 μg/mL).  The crude 
extract, however, showed no antimicrobial activity 
(MIC ≥ 1250 μg/mL against the organisms tested).    
The major component in the crude CH2Cl2 
leaf extract of Tabebuia bahamensis was identified 
by NMR to be ursolic acid (Figure 2).  The 1H and 13C 
NMR spectra were consistent with those previously 
reported for this compound (Moghaddam et al., 2007; 
Silva et al., 2008; Keat et al., 2010) (Table 1).     
 
 
9:1 
hexane/EtOAc 
4:1 
hexane/EtOAc 
1:1 
hexane/EtOAc 
Figure 2. Ursolic acid 
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Table 1.  NMR assignments of ursolic acid. 
Position Carbon δ 13C Proton δ 1H 
1 36.30 1.56 
2 26.98 1.44 
3 76.81 3.00 (dt, J = 10.1, 5.0 Hz, 1H) 
4 38.37 - 
5 54.76 0.67 
6 17.99 1.30, 1.47 
7 32.69 1.27 
8 39.09 - 
9 47.00 1.47 
10 36.52 - 
11 22.84 1.85 
12 124.55 5.13 (t, J = 3.7 Hz, 1H) 
13 138.17 - 
14 41.63 - 
15 27.53 1.00, 1.79 
16 23.79 1.52, 1.93 
17 46.81 - 
18 52.36 2.10 
19 38.49 0.92 
20 38.42 1.30 
21 30.17 1.27, 1.42 
22 38.21 1.53 
23 28.25 0.89 (s, 3H) 
24 16.07 0.67 (s, 3H) 
25 15.22 0.86 (s, 3H) 
26 16.91 0.75 (s, 3H) 
27 23.26 1.04 (s, 3H) 
28 178.24 - 
29 17.01 0.81 (d, J = 6.4 Hz, 3H) 
30 21.07 0.91 (s, 3H) 
Tests with ursolic acid for in-vitro cytotoxic 
activity against MDA-MB-231, MCF-7, and 5637 
cells and proved to be extremely cytotoxic with IC50 
of 14.8±1.0, 14.9±0.5, and 18.8±0.4 μg/mL, respectively.  
In addition, the ursolic acid also showed antibacterial 
activity against S. aureus, with an MIC equal to 156 
μg/mL, but was inactive against the other bacteria 
and fungi that were screened. 
 
DISCUSSION 
Ursolic acid (3β-hydroxy-urs-12-en-28-oic 
acid) is a triterpenoid that is common in many plants 
and can  
be considered pharmacologically important for 
several biological activities.  The cytotoxic effects of 
ursolic acid observed in this study are consistent with 
previous studies that have reported ursolic acid as an 
antitumor agent in several stages of tumor 
development (Ovesná et al., 2004).  Ursolic acid has 
also induced apoptosis in tumor cells and prevented 
malignant transformation of normal cells (Novotný et 
al., 2001).   
The cytotoxic effects of ursolic acid are 
apparently due to the ability of the compound to 
block the cell cycle progression in the G1 phase and 
trigger apoptosis (Ma et al., 2005).  As a result, the 
antiproliferative and apoptotic activities of ursolic 
acid could potentially to be useful for treatment of 
hormone refractory and androgen-sensitive prostate 
cancer (Kassi et al., 2007).  A structure-activity study 
by Ma et al., (2005) has revealed that the carbonyl 
group at C17 and a hydrogen-bond-donor group at C3 
and/or C28 are necessary for the cytotoxic effect.  The 
antibacterial activity of ursolic acid against S. aureus 
has been reported in other studies (Fontanay et al., 
2008; Wolska et al., 2010). 
Ursolic acid has been demonstrated to be active 
against promastigotes of Leishmania amazonensis 
and L. donovani (Peixoto et al., 2011; Adebayo et al., 
2013), epimastigotes of Trypanosoma cruzi (Abe et 
al., 2002), and trypomastigotes of T. brucei 
rhodesiense (van Baren et al., 2006).  Ursolic acid is 
also active as a hepatoprotective agent, and is known 
to be effective against acute, chemically-induced liver 
injury and chronic liver fibrosis and cirrhosis (Liu, 
1995, 2005).   
Ursolic acid acts an anti-inflammatory agent by 
inhibiting histamine release from mast cells and also 
by inhibiting lipoxygenase and cyclooxygenase 
activity (Liu, 1995; Ikeda et al., 2008).  Pharma-
cologically, ursolic acid has anti-hyperlipidemia and 
an antioxidant activity (Liu, 1995; Somova et al., 
2003) along with demonstrated anxiolytic and anti-
depressant (Pemminati et al., 2011; Machado et al., 
2012) activities in rodent models.  Plant extracts con-
taining ursolic acid have also shown aphrodisiac 
effects (Balamurugan et al., 2010; Malviya et al., 
2011).  Ursolic acid is generally considered to be 
non-toxic, showing neither an acute (LD50 = 9.26g/kg) 
nor chronic genetic toxicity in mice (Lu et al., 2009).   
Shrestha et al.: Tabebuia bahamensis:  A Major Source of Pharmacologically Importa
40 
 
Establishing Tabebuia bahamensis as a major 
source of ursolic acid, with a yield of 2.06 percent 
based on the mass of dry leaves, would make the 
ursolic acid readily available.   The cytotoxicity of 
this ursolic acid against MDA-MB-231, MCF-7, and 
5637 cell lines reaffirms the potential of ursolic acid 
to be developed into an efficient anticancer agent.  
The biological activities of ursolic acid are consistent 
with some traditional uses of T. bahamensis. 
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